Low cholesterol rarely announces itself with a clear set of symptoms the way high blood pressure or diabetes might. Most people with moderately low levels feel perfectly fine and never know their numbers are below average unless a blood test reveals it. The concern arises at the extremes: when total cholesterol or LDL cholesterol drops very low, either from a genetic condition, an underlying illness, or aggressive medication, a handful of health risks begin to surface in the research. These risks range from subtle mood changes to a slightly elevated chance of hemorrhagic stroke, and untangling which ones are caused by the low cholesterol itself, rather than by whatever drove it down, turns out to be one of the trickier puzzles in cardiovascular medicine.
How Low Is “Low”?
There is no single universally agreed-upon cutoff for hypocholesterolemia. One common clinical definition places it at a total cholesterol level below the fifth percentile for a person’s age and sex, or below a threshold that epidemiological data link to worse health outcomes.1PubMed. Primary and secondary hypocholesterolemia In practice, doctors tend to pay attention when total cholesterol drops below about 120 mg/dL, or when LDL cholesterol falls below roughly 40 mg/dL. These are the ranges where studies start picking up associations with increased risk for certain problems. For context, the average American adult has a total cholesterol somewhere around 200 mg/dL, so we are talking about numbers far below the usual range.
Worth noting early: “low cholesterol” in everyday conversation usually refers to LDL cholesterol, the type most people are trying to lower with diet or medication. HDL cholesterol being low is a separate issue with its own health implications and is not what this article addresses.
Most People Feel Nothing at All
If your cholesterol is simply on the lower side of normal, you are unlikely to notice any symptoms. Unlike very high cholesterol, which can also be silent but carries well-documented risks, moderately low cholesterol does not produce headaches, fatigue, or any reliable physical sensation. The body can function well across a fairly wide range of cholesterol levels, and many populations around the world maintain naturally low averages without apparent harm.
Where this gets complicated is at the very bottom of the range, or when low cholesterol is a side effect of something else going on in the body. The symptoms people experience in those situations are almost always tied to the underlying cause rather than the cholesterol number itself. That distinction matters because it determines whether the low reading is the problem or just the messenger.
Mood Changes and Mental Health
One of the more persistent findings in the research is a link between very low cholesterol and depression, anxiety, and suicide risk. Cholesterol plays a role in brain cell membranes and in the production of serotonin, so researchers have long wondered whether dropping it too far might affect mood. A review of the literature found that depressed patients with cholesterol levels below 160 mg/dL appeared to be at higher risk of suicidal behavior compared with depressed patients whose cholesterol was in a more typical range.2European Neuropsychopharmacology. Cholesterol in mood and anxiety disorders: review of the literature and new hypotheses
This does not mean that low cholesterol causes depression. The relationship may run in the opposite direction: people who are severely ill, malnourished, or dealing with chronic disease often have both low cholesterol and depressed mood, and the cholesterol level may simply be reflecting poor overall health. Still, the association has been consistent enough across studies that clinicians sometimes take note when a patient presents with both very low cholesterol and significant mood disturbance.
Cognitive function is another area that gets attention. Some people worry that lowering cholesterol too aggressively, particularly with statin drugs, might cause memory problems. The evidence here is genuinely mixed: some research has found correlations between cholesterol reduction and changes in memory, while other studies have not, and overall the picture is inconclusive.3PubMed Central. The effects of cholesterol on learning and memory A scientific statement from the American Heart Association reviewed the available data and concluded that the bulk of observational studies and randomized trial data do not support the idea that statin use or LDL lowering causes dementia or lasting cognitive impairment.4PubMed. Aggressive LDL-C Lowering and the Brain: Impact on Risk for Dementia and Hemorrhagic Stroke
Hemorrhagic Stroke
Perhaps the most concrete medical risk associated with very low cholesterol is a modestly increased chance of hemorrhagic stroke, which is bleeding in the brain rather than a blockage. Cholesterol is a structural component of cell membranes, and the leading theory is that when levels drop very low, blood vessel walls may become more fragile and more prone to rupture. Laboratory work has shown that depleting cholesterol from cell membranes increases their tension and makes them more susceptible to mechanical damage.5PubMed Central. Cholesterol Depletion by MβCD Enhances Cell Membrane Tension and Its Variations-Reducing Integrity
A large meta-analysis of randomized trials found that LDL-lowering therapy was associated with a roughly 16 percent higher relative risk of hemorrhagic stroke. That increase was driven mainly by statin trials and was more pronounced in patients over 65 and those with a history of prior stroke.6PubMed Central. Lipid-Lowering Therapy and Risk of Hemorrhagic Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials A Chinese population study took it further, finding that adults with LDL cholesterol at or below 40 mg/dL had roughly 2.7 times the risk of hemorrhagic stroke compared to those in the 55–70 mg/dL range.7PubMed Central. The risk of ischemic stroke and hemorrhagic stroke in Chinese adults with low-density lipoprotein cholesterol concentrations < 70 mg/dL
These numbers need some perspective. Hemorrhagic stroke is relatively rare to begin with, so a modest relative increase still translates to a small absolute risk for most people. And the benefits of lowering LDL to prevent heart attacks and ischemic strokes (which are far more common) typically outweigh this added bleeding risk by a wide margin. The concern is real but narrow: it matters most for people whose LDL has been pushed to extremely low levels, especially if they are older or already have a history of cerebrovascular disease.8PubMed Central. Low LDL-Cholesterol and Hemorrhagic Risk: Mechanistic Insights and Clinical Perspectives
Genetic Conditions That Cause Extremely Low Cholesterol
There are rare inherited conditions in which the body cannot properly produce or transport cholesterol-carrying lipoproteins. Abetalipoproteinemia is the most well-known example. In this disorder, infants typically develop fatty, foul-smelling stools, vomiting, and failure to gain weight because they cannot absorb dietary fat properly.9PubMed Central. Current Diagnosis and Management of Abetalipoproteinemia As they grow older, the inability to absorb fat-soluble vitamins (A, D, E, and K) leads to a cascade of problems: vision loss from retinal degeneration, nerve damage causing unsteadiness and muscle weakness, anemia, and abnormal bleeding due to clotting factor deficiencies.10PubMed Central. Abetalipoproteinemia: two case reports and literature review
These symptoms are severe and unmistakable, but they develop because of the genetic defect’s effects on fat and vitamin absorption, not simply because cholesterol is low. Treatment focuses on high-dose vitamin E supplementation and dietary modifications to prevent or slow neurological damage. The condition is extremely rare, affecting perhaps one in several hundred thousand people, so it is not what most readers asking about low cholesterol need to worry about. But it does illustrate an important point: when cholesterol is very low because of a specific biological cause, the symptoms tend to come from that cause rather than from the cholesterol number itself.
When Medication Pushes Cholesterol Very Low
Modern cholesterol-lowering drugs, especially the newer PCSK9 inhibitors used alongside statins, can drive LDL cholesterol down to levels previously seen only in genetic conditions, sometimes below 15 mg/dL. This has understandably raised safety questions. The evidence so far is largely reassuring. An analysis of the FOURIER trial found no serious adverse events even in patients whose LDL dropped below 15 mg/dL, and these patients actually experienced further improvements in cardiovascular outcomes.11Biomedicine & Pharmacotherapy. Review Safety of PCSK9 inhibitors
A pooled analysis of trials using PCSK9 inhibitors found that very low LDL was associated with about a 23 percent reduction in major cardiovascular events without significant increases in neurocognitive disorders, diabetes, muscle problems, liver issues, cataracts, or cancer compared to control groups.12PubMed Central. Safety and Efficacy of Achieving Very Low LDL Cholesterol Concentrations with PCSK9 Inhibitors Long-term follow-up of patients taking evolocumab for years showed no decline in executive function, even among those who had maintained very low LDL levels throughout the study period.13PubMed. Long-Term Cognitive Safety of Achieving Very Low LDL Cholesterol with Evolocumab
One concern that people frequently raise is whether extremely low cholesterol might interfere with hormone production, since cholesterol is the raw material for steroid hormones like cortisol, testosterone, and estrogen. A study that specifically measured these hormones in patients taking evolocumab found no clinically relevant changes in cortisol, testosterone, estrogen, or related hormones after 12 weeks of treatment, even as LDL dropped dramatically.14PubMed Central. Effects of evolocumab therapy and low LDL-C levels on vitamin E and steroid hormones in Chinese and global patients with type 2 diabetes The body appears to have enough internal cholesterol production to sustain hormone synthesis even when circulating LDL is very low.
Infection Risk and Immune Function
Some older observational studies noticed that hospitalized patients with low LDL cholesterol were more likely to develop sepsis or end up in intensive care. At first glance, this looks alarming. But when researchers adjusted for factors like age, sex, and existing diseases, the association between low LDL and sepsis essentially disappeared.15JAMA Network Open. Association Between Low-Density Lipoprotein Cholesterol Levels and Risk for Sepsis Among Patients Admitted to the Hospital With Infection That is a strong hint that the low cholesterol was not causing the infections but was instead a marker for being sicker in general.
A more recent study tried a different approach, using genetic scores that predict a person’s lifelong LDL level to see whether naturally lower cholesterol increases infection risk. Interestingly, genetically lower LDL was actually associated with a reduced risk of bacterial pneumonia and sepsis, not an increased one.16PubMed Central. Low LDL cholesterol and risk of bacterial and viral infections: observational and Mendelian randomization studies This suggests that the association between low LDL and infections in hospital patients is likely driven by the diseases that pulled cholesterol down, not by the low cholesterol weakening the immune system.
The Mortality Puzzle
One of the most confusing findings in the cholesterol literature is that people with very low total cholesterol sometimes have higher overall death rates than people with moderate levels. Several large studies have found a U-shaped relationship: both very high and very low total cholesterol are associated with increased mortality. One analysis found that total cholesterol below 120 mg/dL was associated with roughly double the all-cause mortality risk and more than double the cancer mortality risk compared to levels around 200 mg/dL.17PubMed Central. A nonlinear association of total cholesterol with all-cause and cause-specific mortality
A large study spanning both Chinese cohorts and the UK Biobank, after excluding people on lipid-lowering drugs, those with existing heart disease, stroke, cancer, and those who died within two years of enrollment, still found that low cholesterol was associated with higher all-cause and cancer mortality.18Engineering. Low and Decreasing Cholesterol Levels and Risk of All-Cause and Cause-Specific Mortality: A Prospective and Longitudinal Cohort Study The researchers took unusual care to rule out reverse causality by excluding early deaths and people with preexisting conditions that could drive cholesterol down.
Reverse causality is the elephant in the room with all of these findings. Many serious diseases, including cancer, liver failure, and chronic infections, lower cholesterol as they progress. So when a study finds that people with low cholesterol die sooner, it could simply mean that many of them already had undiagnosed illnesses dragging their numbers down. A long-term follow-up study in a Japanese-American population found that people who maintained low cholesterol over a 20-year period still had the worst mortality outcomes, which suggests that reverse causality alone does not fully account for the pattern.19Scientific Reports. Total cholesterol and all-cause mortality by sex and age: a prospective cohort study among 12.8 million adults The honest answer is that researchers still do not completely understand this relationship, and the debate continues about how much of the risk is from the cholesterol itself versus the conditions behind it.
When Low Cholesterol Signals Something Else
In clinical practice, the most important question when a doctor sees unexpectedly low cholesterol is often not “what symptoms is the low cholesterol causing?” but “what is causing the low cholesterol?” A number of conditions can drive cholesterol levels down, and the symptoms a patient experiences usually come from those conditions rather than from the low number on the lab report.
Hyperthyroidism, where the thyroid gland is overactive, can produce low cholesterol along with its own set of symptoms like weight loss, rapid heartbeat, anxiety, and heat intolerance.20PubMed Central. Effects of thyroid dysfunction on lipid profile Liver disease reduces cholesterol because the liver is where most cholesterol is manufactured. Malnutrition and malabsorption conditions lower it because the body lacks the raw materials. Certain cancers can consume cholesterol as tumors grow, and research has shown that a prediagnostic tumor can reduce serum cholesterol levels before the cancer is even discovered.21PubMed Central. Association between prediagnostic glucose, triglycerides, cholesterol and meningioma, and reverse causality
This is why a sudden or unexplained drop in cholesterol on routine bloodwork sometimes prompts further investigation. The cholesterol level itself may not be harming you, but it can serve as an early flag that something else in the body deserves attention.
Low Cholesterol in Pregnancy
Cholesterol normally rises during pregnancy because the body needs it to support fetal development and hormone production. When maternal cholesterol stays low instead of climbing, it may be associated with complications. One study found that preterm birth was nearly five times more common among women with low total cholesterol compared with those in the midrange.22PubMed Central. Preterm delivery and low maternal serum cholesterol level: Any correlation? This is a single study and the numbers should be taken cautiously, but it aligns with the broader understanding that cholesterol plays a structural and hormonal role in pregnancy that makes very low levels potentially problematic.
Pregnant women are generally not prescribed cholesterol-lowering medications (statins are contraindicated in pregnancy), so this issue most commonly arises in women with naturally low levels or with underlying conditions affecting their lipid metabolism. If you are pregnant and your cholesterol is unusually low, it is worth discussing with your doctor, though it is not something that standard prenatal screening always flags.
Separating Cause From Correlation
The recurring theme across almost every area of low-cholesterol research is the difficulty of determining whether the low cholesterol itself is harmful or whether it is simply traveling alongside something that is. When studies use genetic methods to isolate the effect of lifelong low LDL, the results tend to be far less alarming than observational data suggest. People born with genetic variants that keep their LDL naturally low enjoy protection from heart disease without obvious increases in cancer, infection, or cognitive decline. The problems tend to cluster in people whose cholesterol dropped because they became sick, not in people whose cholesterol was always low.
This distinction matters because it changes what you should do about a low cholesterol reading. If your LDL is low because you eat well, exercise, and have favorable genetics, the evidence strongly suggests you are better off, not worse. If your cholesterol suddenly plummeted without any lifestyle change or new medication, that is worth investigating for an underlying cause. And if your doctor has you on aggressive lipid-lowering therapy because of high cardiovascular risk, the clinical trial data consistently show that the cardiovascular benefits outweigh the small and mostly theoretical risks of very low LDL in that context.